Ascidian Toxins with Potential for Drug Development
AbstractAscidians (tunicates) are invertebrate chordates, and prolific producers of a wide variety of biologically active secondary metabolites from cyclic peptides to aromatic alkaloids. Several of these compounds have properties which make them candidates for potential new drugs to treat diseases such as cancer. Many of these natural products are not produced by the ascidians themselves, rather by their associated symbionts. This review will focus mainly on the mechanism of action of important classes of cytotoxic molecules isolated from ascidians. These toxins affect DNA transcription, protein translation, drug efflux pumps, signaling pathways and the cytoskeleton. Two ascidian compounds have already found applications in the treatment of cancer and others are being investigated for their potential in cancer, neurodegenerative and other diseases. View Full-Text
Share & Cite This Article
Watters, D.J. Ascidian Toxins with Potential for Drug Development. Mar. Drugs 2018, 16, 162.
Watters DJ. Ascidian Toxins with Potential for Drug Development. Marine Drugs. 2018; 16(5):162.Chicago/Turabian Style
Watters, Dianne J. 2018. "Ascidian Toxins with Potential for Drug Development." Mar. Drugs 16, no. 5: 162.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.